Sandbox 977

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
The major function of this enzyme is to degrade biogenic amines. MAOAs catalyze the oxidation of serotonin, norepinephrine, and dopamine. Then hydrolyze the oxidative products to give aldehydes or ketones. <ref>Gaweska, Helena. "Structures and Mechanism of the Monoamine Oxidase Family." BioMol Concepts 2 (2011): 365-77. Print.</ref>
The major function of this enzyme is to degrade biogenic amines. MAOAs catalyze the oxidation of serotonin, norepinephrine, and dopamine. Then hydrolyze the oxidative products to give aldehydes or ketones. <ref>Gaweska, Helena. "Structures and Mechanism of the Monoamine Oxidase Family." BioMol Concepts 2 (2011): 365-77. Print.</ref>
== Disease ==
== Disease ==
-
MAOAs remove amino functional groups to leave an oxidized oxygen atom behind, and producing ammonia and hydrogen peroxide. The hydrogen peroxide in a major mediator in the production of hydroxyl radicals in the body. Free hydroxyl radicals in the body has detrimental effects on several organs especially the brain. MAOAs are associated with major depressive disorder and cardiovascular disease. Increased activity of this enzyme can lead to downstream dysregulations of elevation of oxidative stresses, increased platelet activity, and cytokine levels.<ref>Machado-Vieira, R., & G. Mallinger, A. (2012). Abnormal Function of Monoamine Oxidase-A in comorbid Major Depressive disorder and Cardiovascular Disease: Pathophysical and Theraputic Implications (Review). Molecular Medicine Reports, 6, 915-922. Retrieved April 2, 2015, from Scifinder.</ref>
+
MAOAs remove amino functional groups to leave an oxidized oxygen atom behind, and producing ammonia and hydrogen peroxide. The hydrogen peroxide is a major mediator in the production of hydroxyl radicals in the body. Free hydroxyl radicals in the body have detrimental effects on several organs especially the brain. MAOAs are associated with major depressive disorder and cardiovascular disease. Increased activity of this enzyme can lead to downstream dysregulations of elevation of oxidative stresses, increased platelet activity, and cytokine levels.<ref>Machado-Vieira, R., & G. Mallinger, A. (2012). Abnormal Function of Monoamine Oxidase-A in comorbid Major Depressive disorder and Cardiovascular Disease: Pathophysical and Theraputic Implications (Review). Molecular Medicine Reports, 6, 915-922. Retrieved April 2, 2015, from Scifinder.</ref>
== Relevance ==
== Relevance ==
It is important to study MAOAs because they are so harmful to the human body. Many of these effects can be avoided with the use of monoamine oxidase A inhibitors. These inhibitors block the substrate binding sites, keeping free amines from binding and being metabolized by the MAOAs. .<ref>Machado-Vieira, R., & G. Mallinger, A. (2012). Abnormal Function of Monoamine Oxidase-A in comorbid Major Depressive disorder and Cardiovascular Disease: Pathophysical and Theraputic Implications (Review). Molecular Medicine Reports, 6, 915-922. Retrieved April 2, 2015, from Scifinder.</ref>
It is important to study MAOAs because they are so harmful to the human body. Many of these effects can be avoided with the use of monoamine oxidase A inhibitors. These inhibitors block the substrate binding sites, keeping free amines from binding and being metabolized by the MAOAs. .<ref>Machado-Vieira, R., & G. Mallinger, A. (2012). Abnormal Function of Monoamine Oxidase-A in comorbid Major Depressive disorder and Cardiovascular Disease: Pathophysical and Theraputic Implications (Review). Molecular Medicine Reports, 6, 915-922. Retrieved April 2, 2015, from Scifinder.</ref>

Revision as of 22:03, 3 May 2015

Monoamine Oxidase A (MAOA)

Structure of Monoamine Oxidase A (MAOA)

Drag the structure with the mouse to rotate

References

  1. Machado-Vieira, R., & G. Mallinger, A. (2012). Abnormal Function of Monoamine Oxidase-A in comorbid Major Depressive disorder and Cardiovascular Disease: Pathophysical and Theraputic Implications (Review). Molecular Medicine Reports, 6, 915-922. Retrieved April 2, 2015, from Scifinder.
  2. Gaweska, Helena. "Structures and Mechanism of the Monoamine Oxidase Family." BioMol Concepts 2 (2011): 365-77. Print.
  3. Machado-Vieira, R., & G. Mallinger, A. (2012). Abnormal Function of Monoamine Oxidase-A in comorbid Major Depressive disorder and Cardiovascular Disease: Pathophysical and Theraputic Implications (Review). Molecular Medicine Reports, 6, 915-922. Retrieved April 2, 2015, from Scifinder.
  4. Machado-Vieira, R., & G. Mallinger, A. (2012). Abnormal Function of Monoamine Oxidase-A in comorbid Major Depressive disorder and Cardiovascular Disease: Pathophysical and Theraputic Implications (Review). Molecular Medicine Reports, 6, 915-922. Retrieved April 2, 2015, from Scifinder.
  5. Gaweska, Helena. "Structures and Mechanism of the Monoamine Oxidase Family." BioMol Concepts 2 (2011): 365-77. Print.
  6. E. Jones, T., Giurato, L., Guccione, S., & R. Ramsay, R. (2007). Interactions of Imidazoline Ligands with the Active Site of Purified Monoamine Oxidase A. The FEBS Journal, 1567-1575. Retrieved January 1, 2015, from Scifinder.
Personal tools